Intellicheck CTO receives 77,000 stock options
Intellicheck, Inc. Chief Technology Officer Jonathan Robins received a grant of stock options covering 77,000 shares of common stock.
Rhea-AI Filing Summary
Intellicheck, Inc. Chief Technology Officer Jonathan Robins received a grant of stock options covering 77,000 shares of common stock. The options have an exercise price of $5.6000 per share and relate to common stock with $.001 par value.
According to the terms, one-third of the option vests on the first anniversary of the grant date, with the remaining two-thirds vesting quarterly over the following two years. The options expire on 2033-03-24, and Robins’ reported holdings after this grant are 77,000 derivative securities, held directly.
This grant is compensation-related and does not represent an open-market purchase or sale of Intellicheck shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 77,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years
FAQ
What did Intellicheck (IDN) report in this Form 4 for Jonathan Robins?
How many Intellicheck (IDN) stock options were granted to the CTO?
What is the exercise price and expiration date of the Intellicheck (IDN) options granted?
How do the Intellicheck (IDN) CTO’s options vest over time?
Does the Intellicheck (IDN) Form 4 show any open-market buying or selling by the CTO?
Is the Intellicheck (IDN) CTO’s ownership after this Form 4 primarily direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.